Etanercept for treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
Frangoul
Haydar
H
Koyama
Tatsuki
T
Domm
Jennifer
J
D055371:Acute Lung Injury / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D000068800:Etanercept; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000401:mortality; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000069285:Infliximab; D053208:Kaplan-Meier Estimate; D011014:Pneumonia / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D011379:Prognosis; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D015996:Survival Rate; D013577:Syndrome; D014184:Transplantation, Homologous / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab; D000068800:Etanercept